Literature DB >> 17452444

Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase.

Nina Jones1, W Rod Hardy, Matthew B Friese, Claus Jorgensen, Matthew J Smith, Neil M Woody, Steven J Burden, Tony Pawson.   

Abstract

Shc family proteins serve as phosphotyrosine adaptor molecules in various receptor-mediated signaling pathways. In mammals, three distinct Shc genes have been described that encode proteins characterized by two phosphotyrosine-interaction modules, an amino-terminal phosphotyrosine binding (PTB) domain and a carboxy-terminal Src homology 2 domain. Here, we report the analysis of an uncharacterized fourth Shc family protein, ShcD/Shc4, that is expressed in adult brain and skeletal muscle. Consistent with this expression pattern, we find that ShcD can associate via its PTB domain with the phosphorylated muscle-specific kinase (MuSK) receptor tyrosine kinase and undergo tyrosine phosphorylation downstream of activated MuSK. Interestingly, additional sites of tyrosine phosphorylation, including a novel Grb2 binding site, are present on ShcD that are not found in other Shc family proteins. Activation of MuSK upon agrin binding at the neuromuscular junction (NMJ) induces clustering and tyrosine phosphorylation of acetylcholine receptors (AChRs) required for synaptic transmission. ShcD is coexpressed with MuSK in the postsynaptic region of the NMJ, and in cultured myotubes stimulated with agrin, expression of ShcD appears to be important for early tyrosine phosphorylation of the AChR. Thus, we have characterized a new member of the Shc family of docking proteins, which may mediate a specific aspect of signaling downstream of the MuSK receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452444      PMCID: PMC1951494          DOI: 10.1128/MCB.00184-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  An alternative to SH2 domains for binding tyrosine-phosphorylated proteins.

Authors:  W M Kavanaugh; L T Williams
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

2.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

Authors:  G Pelicci; L Lanfrancone; F Grignani; J McGlade; F Cavallo; G Forni; I Nicoletti; F Grignani; T Pawson; P G Pelicci
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

Review 3.  Evolution of Shc functions from nematode to human.

Authors:  L Luzi; S Confalonieri; P P Di Fiore; P G Pelicci
Journal:  Curr Opin Genet Dev       Date:  2000-12       Impact factor: 5.578

4.  A single pulse of agrin triggers a pathway that acts to cluster acetylcholine receptors.

Authors:  Peggy Mittaud; Alain A Camilleri; Raffaella Willmann; Susanne Erb-Vögtli; Steven J Burden; Christian Fuhrer
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.

Authors:  M Rozakis-Adcock; R Fernley; J Wade; T Pawson; D Bowtell
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

6.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.

Authors:  M Rozakis-Adcock; J McGlade; G Mbamalu; G Pelicci; R Daly; W Li; A Batzer; S Thomas; J Brugge; P G Pelicci; J Schlessinger; T Pawson
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

7.  Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells.

Authors:  M Ohmichi; K Matuoka; T Takenawa; A R Saltiel
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

8.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.

Authors:  Z Songyang; S E Shoelson; J McGlade; P Olivier; T Pawson; X R Bustelo; M Barbacid; H Sabe; H Hanafusa; T Yi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

9.  Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction.

Authors:  Alexander J Finn; Guoping Feng; Ann Marie Pendergast
Journal:  Nat Neurosci       Date:  2003-07       Impact factor: 24.884

10.  The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.

Authors:  D Stein; J Wu; S A Fuqua; C Roonprapunt; V Yajnik; P D'Eustachio; J J Moskow; A M Buchberg; C K Osborne; B Margolis
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  19 in total

1.  Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Authors:  Josie Ursini-Siegel; Sean Cory; Dongmei Zuo; William R Hardy; Elton Rexhepaj; Sonya Lam; Babette Schade; Karin Jirstrom; Eva Bjur; Ciriaco A Piccirillo; David Denardo; Lisa M Coussens; Donal J Brennan; William M Gallagher; Morag Park; Tony Pawson; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Biologically active substances-enriched diet regulates gonadotrope cell activation pathway in liver of adult and old rats.

Authors:  Hanna Oszkiel; Jacek Wilczak; Michał Jank
Journal:  Genes Nutr       Date:  2014-08-26       Impact factor: 5.523

3.  Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.

Authors:  Melanie K B Wills; Ava Keyvani Chahi; Hayley R Lau; Manali Tilak; Brianna D Guild; Laura A New; Peihua Lu; Kévin Jacquet; Susan O Meakin; Nicolas Bisson; Nina Jones
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

4.  Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.

Authors:  Alberto Azzalin; Elena Moretti; Eloisa Arbustini; Lorenzo Magrassi
Journal:  J Neurooncol       Date:  2014-07-26       Impact factor: 4.130

5.  The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.

Authors:  Eric Haines; Caroline Saucier; Audrey Claing
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

Review 6.  To build a synapse: signaling pathways in neuromuscular junction assembly.

Authors:  Haitao Wu; Wen C Xiong; Lin Mei
Journal:  Development       Date:  2010-04       Impact factor: 6.868

7.  The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.

Authors:  Elisa Bergamin; Peter T Hallock; Steven J Burden; Stevan R Hubbard
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

8.  Protective Effects of ShcA Protein Silencing for Photothrombotic Cerebral Infarction.

Authors:  Jeong-Ah Hwang; Nara Shin; Hyo Jung Shin; Yuhua Yin; Hyeok Hee Kwon; Hyewon Park; Juhee Shin; Song I Kim; Dong Woon Kim; Hee-Jung Song
Journal:  Transl Stroke Res       Date:  2020-11-26       Impact factor: 6.829

9.  Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.

Authors:  Michal Kostas; Ellen Margrethe Haugsten; Yan Zhen; Vigdis Sørensen; Patrycja Szybowska; Elisa Fiorito; Susanne Lorenz; Nina Jones; Gustavo Antonio de Souza; Antoni Wiedlocha; Jørgen Wesche
Journal:  Mol Cell Proteomics       Date:  2018-01-25       Impact factor: 5.911

10.  Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients.

Authors:  Duygu Selcen; Margherita Milone; Xin-Ming Shen; C Michel Harper; Anthony A Stans; Eric D Wieben; Andrew G Engel
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.